Central nervous system portfolio covering antidepressants, anticonvulsants, migraine, ADHD, and neurodegeneration medicines.
Sistema Nervoso Central is Libbs Farmacêutica's CNS portfolio, presented on a dedicated official page aimed at healthcare professionals, with positioning around mental-health treatment and reducing stigma. It lists 25 products including antidepressants across several generations (Reconter escitalopram, Cebrilin paroxetine, Verotina fluoxetine, Velija duloxetine, Voextor vortioxetine, Aymee vilazodone, Zetron XL bupropion).
The portfolio also covers anticonvulsants (Egide topiramate, Jolik pregabalin, Lakos lacosamide), wakefulness and ADHD agents (Stavigile modafinil, Lysdexa lisdexamfetamine), the Sumax sumatriptan migraine family, the galcanezumab biologic Emgality, Alzheimer's agents Zider (memantine) and Coglive (galantamine), and anxiolytic Ansitec.
Eurofarma
Eurofarma Produtos
eurofarma.com.br
Servier
Servier Produtos
servier.com.br
União Química
Uniao Quimica Produtos
uniaoquimica.com.br
| Attribute | Sistema Nervoso Central | Eurofarma Produtos | Servier Produtos | Uniao Quimica Produtos | |
|---|---|---|---|---|---|
| Provider | | | | | |
| Founded | 1958 | 1972 | — | — | |
| Sells To | Consumers, Enterprise | Consumers | — | — | |
| Pricing Model | Recurring, Software | Recurring, Software, Transactional | — | — | |
| Ownership | Private | Public | — | — |
Provider
Founded 1958
Sells To Consumers, Enterprise
Pricing Model Recurring, Software
Ownership Private
Provider
Founded 1972
Sells To Consumers
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
Exeltis central nervous system medicines target psychiatric and neurological disorders.
Lundbeck's portfolio of registered therapies for neurological and psychiatric brain diseases, marketed across more than 80 countries.
Supernus commercial portfolio of products treating neurological and psychiatric conditions including ADHD, epilepsy, Parkinson's disease, and migraine.
Prescription medicines from EMS for pharmacists, physicians and healthcare professionals across practically all medical specialties.
EMS's branded-medicines business area, marketing EMS-owned medicine brands through retail pharmacies alongside its other units.
EMS's generic-medicines unit, Brazil's generics market leader since 2013, supplying pharmacies, distributors and public drug programs.
Farma is Cristália's retail prescription-medicines portfolio spanning pain, mental health, dermatology, oncology, and endocrinology.
EMS's over-the-counter self-care medicines unit, serving self-medicating consumers through Brazil's retail point-of-sale channel.
Exeltis central nervous system medicines target psychiatric and neurological disorders.
Lundbeck's portfolio of registered therapies for neurological and psychiatric brain diseases, marketed across more than 80 countries.
Supernus commercial portfolio of products treating neurological and psychiatric conditions including ADHD, epilepsy, Parkinson's disease, and migraine.
Prescription medicines from EMS for pharmacists, physicians and healthcare professionals across practically all medical specialties.
EMS's branded-medicines business area, marketing EMS-owned medicine brands through retail pharmacies alongside its other units.
EMS's generic-medicines unit, Brazil's generics market leader since 2013, supplying pharmacies, distributors and public drug programs.
Farma is Cristália's retail prescription-medicines portfolio spanning pain, mental health, dermatology, oncology, and endocrinology.
EMS's over-the-counter self-care medicines unit, serving self-medicating consumers through Brazil's retail point-of-sale channel.
